ADC Therapeutics SA Form 6-K Summary
Business Context and Reporting Period
ADC Therapeutics SA filed a Form 6-K as a foreign private issuer for the month of June 2021. The filing was submitted on June 4, 2021, under Commission File Number 001-39071. The company files annual reports on Form 20-F.
Financial Results and Key Metrics
The filing text provided is a cover report and does not include revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide information regarding changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing identifies Exhibit 99.1 as a press release dated June 4, 2021, but the press release content is not included in the provided text. Accordingly, guidance, management commentary, risks, contingencies, and unusual items cannot be assessed.
Investor Verification Items
- Review Exhibit 99.1, the June 4, 2021 press release, for the substantive disclosure.
- Verify whether the omitted exhibit contains financial results, clinical or regulatory updates, financing information, guidance, or other material developments.
- Confirm the filing’s underlying period and any event date described in the press release.